Similarly, overexpression of TOP2A was associated with advance histological grading, vascular invasion, and an early age onset of HCC [59], while CDKN3 was reported as part of a vascular invasion signature in HCC [60] and has been implicated in other malignancies including breast and prostate cancers [61]. The gene discussed is CDKN3; the disease is prostate cancer.